tranilast has been researched along with Food-Hypersensitivity* in 4 studies
1 trial(s) available for tranilast and Food-Hypersensitivity
Article | Year |
---|---|
Inhibition of interferon-gamma and interleukin-2 production from lymphocytes stimulated with food antigens by an anti-allergic drug, Tranilast, in patients with food-sensitive atopic dermatitis.
N(3',4'-dimethoxycinnamoyl) anthranilic acid (Tranilast) inhibits antibody-mediated hypersensitivity reactions, and is an effective drug for patients with bronchial asthma or allergic rhinitis. Interferon-gamma (IFN-gamma) production of ovalbumin (OA)-stimulated peripheral blood mononuclear cells (PBMCs) from hen's egg-sensitive patients with atopic dermatitis (AD) was significantly higher than those of healthy controls. Tranilast inhibited this IFN-gamma production. Moreover, interleukin-2 (IL-2) production of OA-stimulated PBMCs from hen's egg-sensitive patients with AD was also inhibited by Tranilast. Our results suggest that Tranilast can be used to the patients with food sensitive AD. Topics: Anti-Allergic Agents; Cells, Cultured; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Food Hypersensitivity; Humans; Infant; Interferon-gamma; Interleukin-2; Lymphocytes; ortho-Aminobenzoates; Ovalbumin | 1994 |
3 other study(ies) available for tranilast and Food-Hypersensitivity
Article | Year |
---|---|
Cell action mechanism of tranilast--effect on the expression of HLA-class II antigen.
We tested the effect of Tranilast [N-(3',4'-dimethoxycinnamoyl anthranilic acid)], one of the anti-allergic agents, on the induction of interleukin 2 (IL2) responsiveness of lymphocytes from patients with bronchial asthma or hen-egg allergy following stimulation with Dermatophagoides farinae (Df) or ovalbumin (OVA), respectively. Mononuclear cells pretreated with Tranilast for 12 h failed to respond to IL2 following incubation with Df or OVA. Also Tranilast inhibited purified protein derivative (PPD)-induced IL2 responsiveness of normal lymphocytes but not the Con A-induced IL2 responsiveness of normal or allergen-sensitized lymphocytes. These results suggested that Tranilast has some immunosuppressive effect in that it inhibits antigen-induced IL2 responsiveness. Separation of potential target cells of Tranilast disclosed that antigen-presenting adherent cells were more susceptible to Tranilast than IL2-responding T-cell rich populations. Expression of HLA-DR and -DQ antigens but not DP antigens on macrophages, was significantly suppressed by treatment with Tranilast, although Tranilast scarcely decreased HLA class II antigens expression on B-cells. The suppression was overcome by interferon-gamma, which was known as an inducer for class II antigen expression. Taken together, Tranilast may suppress antigen-induced IL2 responsiveness by inhibiting HLA-DR and HLA-DQ antigens on macrophages. Topics: Adult; Animals; Antigens, Dermatophagoides; Asthma; Child, Preschool; Food Hypersensitivity; Glycoproteins; Histamine H1 Antagonists; HLA-D Antigens; Humans; In Vitro Techniques; Infant; Interleukin-2; Lymphocytes; Macrophages; Mites; ortho-Aminobenzoates; Ovalbumin | 1993 |
Inhibition of proliferative responses of lymphocytes to food antigens by an anti-allergic drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (Tranilast) in children with atopic dermatitis.
Experimental studies have shown that N(3',4'-dimethoxycinnamoyl) anthranilic acid (Tranilast) inhibits reaginic antibody-mediated hypersensitivity reactions, and it has been demonstrated to be an effective drug for patients with bronchial asthma. On the other hand, from the nature of the cellular infiltrate seen in eczematous lesions, it appears that some form of cell-mediated immunity may be involved in addition to IgE-mediated immunity in the pathogenesis of atopic dermatitis (AD). Moreover, we have previously reported that the proliferative responses of peripheral blood mononuclear cells (PBMCs) to ovalbumin (OA) or bovine serum albumin (BSA) in children with AD who are sensitive to hen's egg or cow's milk were significantly higher than those of healthy children and hen's egg or cow's milk sensitive children with immediate symptoms. In this study, we have showed that the proliferative responses of PBMCs to OA were dose-dependently inhibited by Tranilast on patients with AD. The responding cells to OA were shown, through separation experiments, to be T cells, and the proliferative responses of T cells to OA were also dose-dependently inhibited by Tranilast. Moreover, the inhibition was thought to occur at the initial stage of the proliferative reactions. These results suggest that Tranilast can be clinically applied to patients with AD. Topics: Antigens; Child; Child, Preschool; Dermatitis, Atopic; Food; Food Hypersensitivity; Histamine H1 Antagonists; Humans; In Vitro Techniques; Infant; Lymphocyte Activation; ortho-Aminobenzoates; Ovalbumin; Serum Albumin, Bovine | 1992 |
[Effects of anti-allergic drugs on blastogenesis of lymphocytes to food antigens].
Topics: Food Hypersensitivity; Humans; Lymphocyte Activation; ortho-Aminobenzoates; Ovalbumin; Serum Albumin, Bovine | 1987 |